Cancer Patients and Survivors Return to the Statehouse to Rally Legislators
Ohio Must Do Better to Reduce the Burden of Cancer
Ohio Must Do Better to Reduce the Burden of Cancer
This morning, House Speaker Kevin McCarthy proposed concepts to address the debt limit that would jeopardize Americans’ access to meaningful, affordable health care by implementing work requirements for the Medicaid health insurance program and threaten federally-funded cancer research by shrinking discretionary spending.
ANNAPOLIS, MD – APRIL 17, 2023 – Last week, HB 1217 / SB 805 landed on Governor Wes Moore’s desk following its near-unanimous passage in the Senate and House of Delegates and representing a victory for cancer patients across Maryland.
PROVIDENCE, RI – April 16, 2023 – A statement from Ryan Strik, Director of Government Relations at the American Cancer Society Cancer Action Network in Rhode Island, follows on the death of Rhode Island’s Majority Whip and the second-longest serving member of the Senate, Maryellen Goodwin, from h
Dozens of cancer patients, survivors, and caregivers met with members of the Nevada State Legislature in Carson City Wednesday. The meetings were part of the American Cancer Society Cancer Action Network’s (ACS CAN) ‘Cancer Action Day’ which is held annually at the state capitol. Volunteers asked lawmakers to support Assembly Bill 155 which, if enacted, would expand access to biomarker testing in Nevada.
Patient groups representing millions of people with serious health conditions released a statement today to thank the DOJ for requesting a stay in the ruling of the Braidwood v. Becerra case, which threatens coverage of USPSTF recommended preventive services without cost sharing as required under the ACA.
Attorneys General for six states and DC today announced a $462 million multi-state settlement to be paid out by JUUL Labs, following an investigation into its underage marketing practices to attract youth to its addictive e-cigarettes.
ALBANY, NY – APRIL 12, 2023 – Earlier today, JUUL announced it will pay $462 million to settle a multi-state investigation into its underage marketing practices to attract young consumers to its addictive e-cigarettes.
Our organizations, representing patients with serious health conditions, condemn Judge Kacsmaryk’s decision which threatens to restrict access to a Food and Drug Administration (FDA)- approved medication and other treatments.